John Johnson - Insider Trading & Ownership

Entity
Individual
Location
Dendreon Corporation, 1301 2 Nd Avenue, Seattle, WA
Summary
The estimated net worth of John Johnson is at least $5.24M dollars as of December 20, 2024. John Johnson is the Executive Chairman, Director of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. (APLT) stock worth about $2.92M. John Johnson is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $1.7M. John Johnson is the Director of Axogen, Inc. and owns shares of Axogen, Inc. (AXGN) stock worth about $528K. John Johnson is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $90.6K.
All Insider Reports
All Insider Reports

Ownership of John Johnson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APLT Applied Therapeutics, Inc. Executive Chairman, Director $2.92M Dec 19, 2024
XERS Xeris Biopharma Holdings, Inc. Director $1.7M Jun 5, 2024
AXGN Axogen, Inc. Director $528K Sep 1, 2024
VSTM Verastem, Inc. Director $90.6K Jun 18, 2024
SBBP Strongbridge Biopharma plc Chief Executive Officer, Director Oct 5, 2021

Insider Transactions Reported by John Johnson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.